NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Entity family
Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.
This funder is selected. Its supporting articles are shown below.
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…